Clinical trials facilitate rigorous and strict testing of new vaccines and treatments, ensuring pharmaceutical companies ...
As companies prepare for the upcoming proxy and annual report season, the following lists some of the key items to ...
Here are some regions that are attracting biotech and pharma companies.
Growth stocks are often shares of companies in rapidly evolving and innovative sectors, such as technology, artificial ...
“The RFK announcement has kind of scrambled some of the traditional thinking [about] a lot of the people that have been ...
In a year and a half, Eli Lilly (NYSE: LLY) has roughly doubled in value. It is now the most valuable pharmaceutical company in the world.
Sen. Elizabeth Warren (D-Mass.) and Rep. Jan Schakowsky (D-Ill.) have introduced legislation that would require ...
Anne Wojcicki, CEO of 23andMe, the struggling DNA testing company, doesn’t think this is the right time to examine her ...
Discover why the stock prices of mRNA therapy creators BioNTech and Moderna have plummeted and whether they are still worth ...
Two billion dollars in investments. 4,500 employees. Regeneron has grown into a major economic engine — and it's now ...
Investor's Business Daily on MSN12h
Profitable Biotech In Buy Zone As Earnings Approach
This biotech stock hit a buy point and a new high. The company's sales and earnings continue to grow with earnings out soon.
Amgen (NASDAQ: AMGN) stock is up 13% this year but has struggled to break out above a tight trading range in recent months.